mTOR activity can drive tau accumulation in AD by increasing translation of tau mRNA via S6K1 activation as well as inhibiting protein phosphatase 2A (PP2A), as the major tau phosphatase.77 Here, RPS6KB1 is linked to Alzheimer disease.